-
RegMed XB is a translational product development platform that brings together Dutch and Flemish public and private stakeholders to accelerate the development of innovative regenerative therapies.
Infrastructure: RegMed XB's Pilot Factory
A seamless pathway for innovators to accelerate, de-risk, and scale regenerative therapies
read more
-
Over 170 Participants Gather in Leuven for the Inaugural Advanced Therapies Summit on October 19th
The first edition of the Advanced Therapies Summit, held on October 19th, was a success. Dr. Bart Geers, Chair of the Board at RegMed XB Flanders, welcomed over 170 participants from both Belgium and across the European Union.
read more
Behind the Scenes: The Purpose and Vision of the RegMed XB Pilot Factory
Recently, the Dutch government conducted interviews with our team to gain insights into the progress of the RegMed XB Pilot Factory.
read more
SBMC invests 4 million euro in New Pilot Production Facility for biomaterials
Smart BioMaterials Consortium (SBMC) and High Tech Campus Eindhoven have joined forces to establish a pilot production facility for smart biomaterials.
read more -
Moonshots (research excellence)
-
Pilot Factory (infrastructure)
The RegMed XB Pilot Factory is one of the largest international infrastructures for regenerative medicine. It brings together all the expertise and infrastructure needed to bring regenerative medicine to the market.
-
RegMed XB's Ecosystem
Health Foundations
The following Dutch health foundations are involved in defining research objectives and provide guidance in the research we conduct to ensure we maintain focus on the patient.
read moreAcademic Partners
RegMed XB works together with (inter)national top-rated academic institutions and collaborates specifically and exclusively with researchers who contribute specific expertise to the Moonshot initiatives.
read moreIndustrial Partners
Partnering with companies offers access to their expertise in designing scalable and feasible products. Currently, we have strong partnerships with the following entities.
read moreGovernmental Partners
RegMed XB receives support from national and local governments to de-risk promising concepts from academia to proof of concept or initial clinical trial stages.
read more -
-
-
-
-
-
-
